From a blog by VALID advisor Christian Sillaber, Senior Researcher on IT-Security
The European Union’s General Data Protection Regulation (GDPR) came into effect on May 25, 2018. It is already clear that the new law, which is in many respects ground-breaking, is struggling to keep up with the pace of technological change. If this issue is not addressed, the GDPR will undermine citizens’ ability to use blockchain.
The core of the problem is that, in addition to the explicit declaration of the rights of the data subject (access to data, data portability, right to erasure, right to correction etc.), the GDPR also mandates that data controllers and processors abide by the principle of “data protection by design and default”. This means designing services and software with privacy as a foundational consideration rather than as an afterthought or add-on. The implied design requirements and goals seem to be at odds with the fundamental ideas behind blockchain and other emerging distributed ledger technologies — in particular transparency, immutability and egalitarian access to the data.
The GDPR applies to the processing of personal data (Art. 2 para. 1 GDPR), that is, any information relating to an identified or — by the use of additional information — identifiable person (Art. 4 para. 1 GDPR). Although the cryptographic identities used by most participants of public permissionless distributed ledger systems are not directly linked to identified natural persons, it is — under certain circumstances — possible to identify participants through additional information (e.g. correlation of the person’s activities with third party data). Therefore, data stored and processed in most public, permissionless blockchain systems should be considered personal data. Little doubt also remains that territorial applicability can also be established for most distributed ledger systems, as they are either (partially) operated from within the EU or are actively used to process data from data subjects located in the EU.
Public, permissionless distributed ledger systems enable their participants to maintain a public database without the need for a trusted central authority or mutual trust. Any participant may enter or leave the system at any time and, therefore, access the data of the ledger at any time.
Image Credit: Valid
News This Week
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Leave A Comment